Anika Therapeutics, Inc. (ANIK)
USD 14.69
(-2.39%)
USD 14.69
(-2.39%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 191.47 Million USD | 13.77% |
| 2022 | 112.97 Million USD | 11.39% |
| 2021 | 101.42 Million USD | 21.47% |
| 2020 | 83.49 Million USD | 61.76% |
| 2019 | 51.61 Million USD | -1.73% |
| 2018 | 52.52 Million USD | 30.25% |
| 2017 | 40.32 Million USD | 40.29% |
| 2016 | 28.74 Million USD | 20.72% |
| 2015 | 23.81 Million USD | 2.56% |
| 2014 | 23.21 Million USD | 16.11% |
| 2013 | 19.99 Million USD | -0.6% |
| 2012 | 20.11 Million USD | -16.28% |
| 2011 | 24.02 Million USD | -0.68% |
| 2010 | 24.19 Million USD | 29.18% |
| 2009 | 18.72 Million USD | 1.97% |
| 2008 | 18.36 Million USD | 48.56% |
| 2007 | 12.36 Million USD | 20.07% |
| 2006 | 10.29 Million USD | 1.53% |
| 2005 | 10.14 Million USD | 0.11% |
| 2004 | 10.12 Million USD | 48.87% |
| 2003 | 6.8 Million USD | -18.54% |
| 2002 | 8.35 Million USD | -20.4% |
| 2001 | 10.49 Million USD | 21.38% |
| 2000 | 8.64 Million USD | 4.17% |
| 1999 | 8.3 Million USD | 50.91% |
| 1998 | 5.5 Million USD | 25.0% |
| 1997 | 4.4 Million USD | 37.5% |
| 1996 | 3.2 Million USD | 28.0% |
| 1995 | 2.5 Million USD | 4.17% |
| 1994 | 2.4 Million USD | 9.09% |
| 1993 | 2.2 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 29.69 Million USD | 6.34% |
| 2024 Q2 | 27.2 Million USD | -8.38% |
| 2024 Q3 | 26.35 Million USD | 8.28% |
| 2023 FY | 128.53 Million USD | 13.77% |
| 2023 Q1 | 35.39 Million USD | 14.93% |
| 2023 Q2 | 32.6 Million USD | -7.89% |
| 2023 Q4 | 27.92 Million USD | -14.4% |
| 2023 Q3 | 32.61 Million USD | 0.05% |
| 2022 Q1 | 25.35 Million USD | -4.06% |
| 2022 Q2 | 28.24 Million USD | 11.38% |
| 2022 FY | 112.97 Million USD | 11.39% |
| 2022 Q3 | 28.57 Million USD | 1.18% |
| 2022 Q4 | 30.79 Million USD | 7.77% |
| 2021 Q2 | 25.28 Million USD | 3.04% |
| 2021 FY | 101.42 Million USD | 21.47% |
| 2021 Q4 | 26.43 Million USD | 5.0% |
| 2021 Q1 | 24.53 Million USD | 7.56% |
| 2021 Q3 | 25.17 Million USD | -0.43% |
| 2020 FY | 83.49 Million USD | 61.76% |
| 2020 Q1 | 20.48 Million USD | 25.49% |
| 2020 Q2 | 19.08 Million USD | -6.83% |
| 2020 Q4 | 22.81 Million USD | 8.01% |
| 2020 Q3 | 21.12 Million USD | 10.68% |
| 2019 FY | 51.61 Million USD | -1.73% |
| 2019 Q1 | 11.93 Million USD | 17.04% |
| 2019 Q2 | 11.66 Million USD | -2.2% |
| 2019 Q3 | 11.69 Million USD | 0.26% |
| 2019 Q4 | 16.32 Million USD | 39.53% |
| 2018 FY | 52.52 Million USD | 30.25% |
| 2018 Q4 | 10.19 Million USD | 2.63% |
| 2018 Q1 | 21.25 Million USD | 94.18% |
| 2018 Q3 | 9.93 Million USD | -10.92% |
| 2018 Q2 | 11.15 Million USD | -47.53% |
| 2017 Q4 | 10.94 Million USD | 2.62% |
| 2017 Q2 | 9.42 Million USD | 1.33% |
| 2017 Q1 | 9.29 Million USD | 10.06% |
| 2017 Q3 | 10.66 Million USD | 13.2% |
| 2017 FY | 40.32 Million USD | 40.29% |
| 2016 FY | 28.74 Million USD | 20.72% |
| 2016 Q4 | 8.44 Million USD | 18.94% |
| 2016 Q3 | 7.1 Million USD | 0.78% |
| 2016 Q2 | 7.04 Million USD | 14.6% |
| 2016 Q1 | 6.14 Million USD | -18.45% |
| 2015 Q4 | 7.54 Million USD | 40.4% |
| 2015 Q2 | 5.2 Million USD | -8.8% |
| 2015 Q1 | 5.7 Million USD | 0.83% |
| 2015 FY | 23.81 Million USD | 2.56% |
| 2015 Q3 | 5.37 Million USD | 3.26% |
| 2014 Q4 | 5.65 Million USD | -6.43% |
| 2014 Q3 | 6.04 Million USD | 5.32% |
| 2014 FY | 23.21 Million USD | 16.11% |
| 2014 Q1 | 5.77 Million USD | 30.46% |
| 2014 Q2 | 5.73 Million USD | -0.69% |
| 2013 FY | 19.99 Million USD | -0.6% |
| 2013 Q4 | 4.42 Million USD | -7.85% |
| 2013 Q3 | 4.8 Million USD | -8.09% |
| 2013 Q2 | 5.22 Million USD | -5.43% |
| 2013 Q1 | 5.53 Million USD | 10.44% |
| 2012 Q1 | 4.88 Million USD | -23.69% |
| 2012 Q4 | 5 Million USD | 3.91% |
| 2012 FY | 20.11 Million USD | -16.28% |
| 2012 Q3 | 4.81 Million USD | -10.87% |
| 2012 Q2 | 5.4 Million USD | 10.7% |
| 2011 Q1 | 5.57 Million USD | 0.65% |
| 2011 Q4 | 6.4 Million USD | 2.51% |
| 2011 FY | 24.02 Million USD | -0.68% |
| 2011 Q2 | 5.8 Million USD | 4.14% |
| 2011 Q3 | 6.24 Million USD | 7.51% |
| 2010 FY | 24.19 Million USD | 29.18% |
| 2010 Q3 | 5.68 Million USD | -16.47% |
| 2010 Q2 | 6.8 Million USD | 10.37% |
| 2010 Q4 | 5.54 Million USD | -2.51% |
| 2010 Q1 | 6.16 Million USD | 89.64% |
| 2009 Q2 | 5.02 Million USD | -3.97% |
| 2009 Q1 | 5.22 Million USD | 6.85% |
| 2009 FY | 18.72 Million USD | 1.97% |
| 2009 Q3 | 5.22 Million USD | 4.05% |
| 2009 Q4 | 3.25 Million USD | -37.79% |
| 2008 Q1 | 4.57 Million USD | 6.94% |
| 2008 Q4 | 4.89 Million USD | 12.03% |
| 2008 Q3 | 4.36 Million USD | -3.45% |
| 2008 FY | 18.36 Million USD | 48.56% |
| 2008 Q2 | 4.52 Million USD | -1.14% |
| 2007 Q2 | 2.71 Million USD | 11.96% |
| 2007 FY | 12.36 Million USD | 20.07% |
| 2007 Q4 | 4.28 Million USD | 45.24% |
| 2007 Q3 | 2.94 Million USD | 8.65% |
| 2007 Q1 | 2.42 Million USD | 23.32% |
| 2006 Q2 | 3.1 Million USD | 8.4% |
| 2006 Q4 | 1.96 Million USD | -16.72% |
| 2006 Q3 | 2.35 Million USD | -24.07% |
| 2006 Q1 | 2.86 Million USD | 22.37% |
| 2006 FY | 10.29 Million USD | 1.53% |
| 2005 FY | 10.14 Million USD | 0.11% |
| 2005 Q4 | 2.34 Million USD | -1.26% |
| 2005 Q3 | 2.37 Million USD | -19.21% |
| 2005 Q2 | 2.93 Million USD | 17.86% |
| 2005 Q1 | 2.49 Million USD | -15.19% |
| 2004 Q2 | 2.53 Million USD | 14.31% |
| 2004 FY | 10.12 Million USD | 48.87% |
| 2004 Q4 | 2.93 Million USD | 20.12% |
| 2004 Q3 | 2.44 Million USD | -3.44% |
| 2004 Q1 | 2.21 Million USD | 15.36% |
| 2003 Q1 | 1.92 Million USD | 4.3% |
| 2003 FY | 6.8 Million USD | -18.54% |
| 2003 Q4 | 1.92 Million USD | 40.45% |
| 2003 Q3 | 1.36 Million USD | -14.19% |
| 2003 Q2 | 1.59 Million USD | -17.2% |
| 2002 Q3 | 1.89 Million USD | -22.14% |
| 2002 FY | 8.35 Million USD | -20.4% |
| 2002 Q1 | 2.16 Million USD | 3.3% |
| 2002 Q2 | 2.43 Million USD | 12.44% |
| 2002 Q4 | 1.84 Million USD | -2.87% |
| 2001 FY | 10.49 Million USD | 21.38% |
| 2001 Q4 | 2.1 Million USD | 9.01% |
| 2001 Q3 | 1.92 Million USD | -47.46% |
| 2001 Q1 | 2.8 Million USD | 43.97% |
| 2001 Q2 | 3.66 Million USD | 30.92% |
| 2000 Q4 | 1.94 Million USD | 4.32% |
| 2000 FY | 8.64 Million USD | 4.17% |
| 2000 Q3 | 1.86 Million USD | -16.38% |
| 2000 Q2 | 2.23 Million USD | -14.41% |
| 2000 Q1 | 2.6 Million USD | 8.57% |
| 1999 Q3 | 2.1 Million USD | 5.0% |
| 1999 Q2 | 2 Million USD | 11.11% |
| 1999 FY | 8.3 Million USD | 50.91% |
| 1999 Q1 | 1.8 Million USD | 20.0% |
| 1999 Q4 | 2.4 Million USD | 14.29% |
| 1998 Q2 | 1.3 Million USD | 18.18% |
| 1998 Q3 | 1.6 Million USD | 23.08% |
| 1998 Q4 | 1.5 Million USD | -6.25% |
| 1998 Q1 | 1.1 Million USD | -21.43% |
| 1998 FY | 5.5 Million USD | 25.0% |
| 1997 Q1 | 800 Thousand USD | -38.46% |
| 1997 Q3 | 1 Million USD | 0.0% |
| 1997 FY | 4.4 Million USD | 37.5% |
| 1997 Q2 | 1 Million USD | 25.0% |
| 1997 Q4 | 1.4 Million USD | 40.0% |
| 1996 Q4 | 1.3 Million USD | -7.14% |
| 1996 Q3 | 1.4 Million USD | 40.0% |
| 1996 Q2 | 1 Million USD | 25.0% |
| 1996 Q1 | 800 Thousand USD | 14.29% |
| 1996 FY | 3.2 Million USD | 28.0% |
| 1995 FY | 2.5 Million USD | 4.17% |
| 1995 Q2 | 600 Thousand USD | 0.0% |
| 1995 Q4 | 700 Thousand USD | 16.67% |
| 1995 Q3 | 600 Thousand USD | 0.0% |
| 1995 Q1 | 600 Thousand USD | -14.29% |
| 1994 Q2 | 700 Thousand USD | 16.67% |
| 1994 Q4 | 700 Thousand USD | 16.67% |
| 1994 Q3 | 600 Thousand USD | -14.29% |
| 1994 FY | 2.4 Million USD | 9.09% |
| 1994 Q1 | 600 Thousand USD | 0.0% |
| 1993 FY | 2.2 Million USD | 0.0% |
| 1993 Q3 | 2 Million USD | 1900.0% |
| 1993 Q2 | 100 Thousand USD | 0.0% |
| 1993 Q4 | 600 Thousand USD | -70.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1605.943% |
| Cerus Corporation | 143.15 Million USD | -33.754% |
| OrthoPediatrics Corp. | 137.01 Million USD | -39.743% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1585.391% |
| Talis Biomedical Corporation | 67.18 Million USD | -184.992% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -667.558% |
| Inogen, Inc. | 236.08 Million USD | 18.896% |
| Spectral AI, Inc. | 20.86 Million USD | -817.729% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -241.938% |
| CVRx, Inc. | 76.14 Million USD | -151.471% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -5327.302% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1433.149% |
| Orthofix Medical Inc. | 667.42 Million USD | 71.311% |
| Venus Concept Inc. | 80.47 Million USD | -137.928% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -238.427% |
| Bioventus Inc. | 409.91 Million USD | 53.289% |
| BrainsWay Ltd. | 28.01 Million USD | -583.4% |
| Envoy Medical, Inc. | 17.89 Million USD | -969.812% |
| electroCore, Inc. | 32.03 Million USD | -497.78% |
| IceCure Medical Ltd | 16.87 Million USD | -1034.599% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -351.251% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -985.888% |
| MaxCyte, Inc. | 84.84 Million USD | -125.676% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1442.689% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3211.939% |
| PAVmed Inc | 64.82 Million USD | -195.363% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -274.868% |
| RxSight, Inc. | 103.85 Million USD | -84.377% |
| Sight Sciences, Inc. | 126.44 Million USD | -51.425% |
| SI-BONE, Inc. | 156.35 Million USD | -22.465% |
| TELA Bio, Inc. | 84.18 Million USD | -127.44% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -173.317% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 5.847% |
| LivaNova PLC | 843.54 Million USD | 77.301% |
| 908 Devices Inc. | 68.08 Million USD | -181.25% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 60.406% |
| Nemaura Medical Inc. | 7.13 Million USD | -2582.172% |
| NeuroPace, Inc. | 75.29 Million USD | -154.296% |
| LENSAR, Inc. | 33.33 Million USD | -474.379% |
| Apyx Medical Corporation | 51.01 Million USD | -275.309% |
| Cutera, Inc. | 197.72 Million USD | 3.16% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -672.669% |
| BioSig Technologies, Inc. | 28.53 Million USD | -571.136% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -430.99% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 77.107% |
| Axonics, Inc. | 270.2 Million USD | 29.136% |
| Outset Medical, Inc. | 198.77 Million USD | 3.67% |
| IRIDEX Corporation | 31.81 Million USD | -501.858% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -6.246% |
| IRadimed Corporation | 30.12 Million USD | -535.648% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -2144.198% |
| INVO Bioscience, Inc. | 7.85 Million USD | -2338.149% |
| Telesis Bio, Inc. | 63.48 Million USD | -201.588% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -94.484% |
| Varex Imaging Corporation | 224.8 Million USD | 14.824% |
| Quipt Home Medical Corp. | 148.66 Million USD | -28.795% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1533.328% |
| Pulmonx Corporation | 112.68 Million USD | -69.918% |
| Dynatronics Corporation | 9.9 Million USD | -1832.524% |
| Modular Medical, Inc. | 17.52 Million USD | -992.333% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -848.506% |
| Semler Scientific, Inc. | 38.94 Million USD | -391.668% |
| InMode Ltd. | 215.68 Million USD | 11.223% |
| Bruker Corporation | 1.07 Billion USD | 82.212% |
| Cytosorbents Corporation | 48.33 Million USD | -296.126% |
| DexCom, Inc. | 1.69 Billion USD | 88.678% |
| Align Technology, Inc. | 2.07 Billion USD | 90.78% |
| Viveve Medical, Inc. | 22.17 Million USD | -763.55% |
| ZimVie Inc. | 275.12 Million USD | 30.405% |
| Movano Inc. | 29.69 Million USD | -544.914% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -39.487% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3211.939% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -5327.302% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 68.136% |
| Profound Medical Corp. | 33.6 Million USD | -469.813% |
| Insulet Corporation | 939.9 Million USD | 79.628% |
| enVVeno Medical Corporation | 25.23 Million USD | -658.677% |
| Surmodics, Inc. | 98.69 Million USD | -94.003% |
| iCAD, Inc. | 22.22 Million USD | -761.53% |
| Nuwellis, Inc. | 22.61 Million USD | -746.747% |
| Biotricity, Inc. | 17.18 Million USD | -1014.228% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 57.058% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1459.559% |
| InspireMD, Inc. | 22.95 Million USD | -734.314% |
| PAVmed Inc. | 64.82 Million USD | -195.363% |
| BIOLASE, Inc. | 34.66 Million USD | -452.422% |
| Beyond Air, Inc. | 61.7 Million USD | -210.332% |
| FONAR Corporation | 28.6 Million USD | -569.383% |
| AxoGen, Inc. | 149.33 Million USD | -28.218% |
| Vivani Medical, Inc. | 26.96 Million USD | -610.087% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -8.122% |
| Inari Medical, Inc. | 448.59 Million USD | 57.317% |
| UFP Technologies, Inc. | 58.08 Million USD | -229.624% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -3785.767% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -2930.488% |
| Tenon Medical, Inc. | 16.96 Million USD | -1028.448% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -2489.95% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -334.156% |
| AdaptHealth Corp. | 1.07 Billion USD | 82.237% |
| Sintx Technologies, Inc. | 15.2 Million USD | -1159.621% |
| NanoVibronix, Inc. | 4.97 Million USD | -3750.292% |
| Quanterix Corporation | 118.1 Million USD | -62.13% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1533.328% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -1225.821% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 51.237% |
| TransMedics Group, Inc. | 182.82 Million USD | -4.734% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -582.255% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1625.166% |
| Hyperfine, Inc. | 52.87 Million USD | -262.148% |
| Establishment Labs Holdings Inc. | 172 Million USD | -11.321% |
| Biomerica, Inc. | 6.97 Million USD | -2643.981% |
| Bone Biologics Corporation | 9.42 Million USD | -1930.853% |
| AVITA Medical, Inc. | 80.77 Million USD | -137.035% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1756.958% |
| Silk Road Medical, Inc | 186.35 Million USD | -2.746% |